Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages

Journal of Cellular Biochemistry

Volumn 114, Issue 6, 2013, Pages 1364-1373

  Chang, Yu Cheng ^a   Sheu, Wayne H H ^b   Chien, Yi Shen ^a   Tseng, Pei Chi ^a   Lee, Wen Jane ^b   Chiang, An Na ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

ABCA1 Stability; Cholesterol EFFLUX; ERK; Hyperglycemia; ROS

Indexed keywords

ABC TRANSPORTER A1; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HYPERGLYCEMIA; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; CELLS, CULTURED; CHOLESTEROL; GENE EXPRESSION; GLUCOSE; HYPERGLYCEMIA; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; PROTEIN STABILITY; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; RNA STABILITY; RNA, MESSENGER;

EID: 84876223627     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24478     Document Type: Article

References (40)

1. Brown A, Reynolds LR, Bruemmer D,. 2010. Intensive glycemic control and cardiovascular disease: An update. Nat Rev Cardiol 7: 369-375.
2. Chang YC, Lee TS, Chiang AN,. 2012. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res 53: 1840-1850.
3. Chen M, Li W, Wang N, Zhu Y, Wang X,. 2007. ROS and NF-κB but not LXR mediate IL-1β signaling for the downregulation of ATP-binding cassette transporter A1. Am J Physiol Cell Physiol 292: C1493-C1501.
4. Dey A, Swaminathan K,. 2010. Hyperglycemia-induced mitochondrial alterations in liver. Life Sci 87: 197-214.
5. Evans JL, Goldfine ID, Maddux BA, Grodsky GM,. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622.
6. Frances DE, Ronco MT, Monti JA, Ingaramo PI, Pisani GB, Parody JP, Pellegrino JM, Sanz PM, Carrillo MC, Carnovale CE,. 2010. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: New insights into the insulin effect. J Endocrinol 205: 187-200.
7. Gantman A, Fuhrman B, Aviram M, Hayek T,. 2010. High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. Biochem Biophys Res Commun 391: 523-528.
8. Giacco F, Brownlee M,. 2010. Oxidative stress and diabetic complications. Circ Res 107: 1058-1070.
9. Ichimura A, Ruike Y, Terasawa K, Tsujimoto G,. 2011. miRNAs and regulation of cell signaling. FEBS J 278: 1610-1618.
10. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H,. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945.
11. Krentz AJ,. 2003. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab 5: S19-S27.
12. Marquart TJ, Allen RM, Ory DS, Baldan A,. 2010. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107: 12228-12232.
13. Martinez LO, Agerholm-Larsen B, Wang N, Chen W, Tall AR,. 2003. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278: 37368-37374.
14. Mauerer R, Ebert S, Langmann T,. 2009. High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 41: 126-132.
15. Mazzone T,. 2010. Intensive glucose lowering and cardiovascular disease prevention in diabetes: Reconciling the recent clinical trial data. Circulation 122: 2201-2211.
16. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ,. 2012. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 53: 64-72.
17. Moore KJ, Tabas I,. 2011. Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
18. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S,. 2003. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348: 2294-2303.
19. Ohkuwa T, Sato Y, Naoi M,. 1995. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56: 1789-1798.
20. Oram JF, Heinecke JW,. 2005. ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85: 1343-1372.
21. Oram JF, Vaughan AM,. 2006. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res 99: 1031-1043.
22. Ortmann J, Veit M, Zingg S, Di Santo S, Traupe T, Yang Z, Volzmann J, Dubey RK, Christen S, Baumgartner I,. 2011. Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: Potential role of ROS and ERK. J Clin Endocrinol Metab 96: 220-228.
23. Passarelli M, Tang C, McDonald TO, O'Brien KD, Gerrity RG, Heinecke JW, Oram JF,. 2005. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54: 2198-2205.
24. Patel DC, Albrecht C, Pavitt D, Paul V, Pourreyron C, Newman SP, Godsland IF, Valabhji J, Johnston DG,. 2011. Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS ONE 6: e22142.
25. Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suarez Y, Fernandez-Hernando C,. 2011. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31: 2707-2714.
26. Rayner KJ, Fernandez-Hernando C, Moore KJ,. 2012. MicroRNAs regulating lipid metabolism in atherogenesis. Thromb Haemost 107: 642-647.
27. Reusch JE, Wang CC,. 2011. Cardiovascular disease in diabetes: Where does glucose fit in ? J Clin Endocrinol Metab 96: 2367-2376.
28. Rosenson RS, Brewer HB, Jr., Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L,. 2012. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation 125: 1905-1919.
29. Schmitz G, Langmann T,. 2005. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 1735: 1-19.
30. Shen GX,. 2010. Oxidative stress and diabetic cardiovascular disorders: Roles of mitochondria and NADPH oxidase. Can J Physiol Pharmacol 88: 241-248.
31. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR,. 2003. Efflux and atherosclerosis: The clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23: 1322-1332.
32. Song KH, Park J, Ha H,. 2012. High glucose increases mesangial lipid accumulation via impaired cholesterol transporters. Transplant Proc 44: 1021-1025.
33. Soumian S, Albrecht C, Davies AH, Gibbs RG,. 2005. ABCA1 and atherosclerosis. Vasc Med 10: 109-119.
34. Winiarska K, Drozak J, Wegrzynowicz M, Fraczyk T, Bryla J,. 2004. Diabetes-induced changes in glucose synthesis, intracellular glutathione status and hydroxyl free radical generation in rabbit kidney-cortex tubules. Mol Cell Biochem 261: 91-98.
35. 1 signaling in mesangial cells. Am J Physiol Renal Physiol 295: F1705-F1714.
36. Xue JH, Yuan Z, Wu Y, Liu Y, Zhao Y, Zhang WP, Tian YL, Liu WM, Kishimoto C,. 2010. High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res 86: 141-150.
37. Yamauchi Y, Hayashi M, Abe-Dohmae S, Yokoyama S,. 2003. Apolipoprotein A-I activates protein kinase Cα signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem 278: 47890-47897.
38. Yu X, Murao K, Imachi H, Li J, Nishiuchi T, Hosomi N, Masugata H, Zhang GX, Iwama H, Ishida T,. 2010. Hyperglycemia suppresses ABCA1 expression in vascular smooth muscle cells. Horm Metab Res 42: 241-246.
39. Zhao C, Dahlman-Wright K,. 2010. Liver X receptor in cholesterol metabolism. J Endocrinol 204: 233-240.
40. Zhou X, Yin Z, Guo X, Hajjar DP, Han J,. 2010. Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J Biol Chem 285: 6316-6326.